Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment Urothelial Carcinoma of the Bladder
Clinical trial NCT02202772 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02202772
- Sponsor
- Guarionex J. Decastro
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2026-04-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.